Featured stories

High-priority stories from the last three weeks, ranked by interest.

2 items1 sources2 stocks

REGN - 2 Clear filter ×

Current filter: REGN

GlobeNewswire-Sep 3, 02:33 PM

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law（摘要待生成）

REGN SBS

GlobeNewswire-Sep 2, 10:36 PM

REGN 12-DAY DEADLINE ALERT: Regeneron Pharmaceuticals, Inc. Investors Alerted to September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit

REGN 12-DAY DEADLINE ALERT: Regeneron Pharmaceuticals, Inc. Investors Alerted to September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit（摘要待生成）

REGN